Abaxis, Inc. (NASDAQ:ABAX)
The Company develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Better than BABY
Recs
THE NEED FOR QUICKER MEDICAL DIAGNOSIS
Recs
1000% volume off of good earnings. new 52 high of 29
Recs
Nice cash balance. Planning to submit 7 new analytes to FDA for CLIA waiver consideration, need to keep an eye out to see if they get it. They got 10 in fiscal '07.
Recs
Good growth with good product and repeat sales. Excellent take-over potential. Look for good good buyout multiple.
Recs
a stockpickers dream...microcap, pos yoy earnings, pos cashflow, $0 debt, > 20% growth in revs, earnings, fcf, worldwide sales oppty, PEG 1.34, high potential of exceeding earnings estimates..
Recs
Abaxis has seen its glory days. I've watched this stock climb from $4-5 per share up to over $20. Unless they come up with something new, they will be relying on their reagent discs to supply income.
Recs
May be overpriced
Recs
GROWING RATE OF GROWTH
Recs
they're bleeding from the nose
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 21 - 30 of 30 : « Previous 1 2